Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvi Japan Oppo. Regulatory News (AJOT)

Share Price Information for Avi Japan Oppo. (AJOT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 129.50
Ask: 132.50
Change: 2.00 (1.55%)
Spread: 3.00 (2.317%)
Open: 131.00
High: 131.00
Low: 129.50
Prev. Close: 129.00
AJOT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AVI responds to METI consultation in Japan

30 Mar 2023 07:00

RNS Number : 6681U
AVI Japan Opportunity Trust PLC
30 March 2023
 

30 March 2023

 

Asset Value Investors (AVI) Submits Opinions on Best Practices for Takeovers to theFair Acquisition Study Group of Ministry of Economy, Trade and Industry (METI)

 

 

Asset Value Investors ("AVI") (CEO & CIO: Joe Bauernfreund) submitted opinions on best practices for takeovers to the Fair Acquisition Study Group, in response to the request made by METI as a public consultation announced on 22nd February 2023 (AVI responds to METI consultation in Japan - Asset Value Investors).

 

AVI believes that the uncertainties left behind by the recent judicial decisions on takeover defences have had a detrimental effect on hostile acquisitions and unsolicited takeover bids in Japan. There are real concerns that takeover defence measures may be abused by management to protect their own interests and that they might lead to complacency towards growing corporate value.

If takeover defence measures continue to be used in Japan, we hope that clear and reasonable guidelines will be adopted to alleviate concerns over their arbitrary use to protect management. With this in mind, we have put forward our opinions on the key issues being discussed by the Study Group (details attached in the link above).

 

The summary of our opinions:

l Less emphasis should be placed on management's assessment of corporate value when considering the benefits of a potential takeover, and at least as much importance should be placed on shareholders' assessment of corporate value by considering their views more effectively.

l In all cases a shareholder vote should be required to trigger anti-takeover measures to avoid the risk of arbitrary use by management.

l Shareholders that are deemed allegiant, and have conflicting relationships with management, should be considered to be excluded when checking interests of shareholders for implementing a takeover defence measure.

l When voting on the adoption of takeover defence measure, where the acquirer has an existing ownership, their vote should only be disregarded in exceptional circumstances, such as the rapid acquisition of shares in the open market.

l Upon receipt of a takeover proposal by the management, a prompt report should be made to the board of directors prior to any initial evaluation of its seriousness or validity.

l In cases where a takeover proposal was rejected, detailed objective reasons as to why the proposed acquisition would not enhance corporate value and how the incumbent management would provide greater value should be disclosed.

l Discouraging hostile acquisitions or creating an unreasonable delay by endlessly asking the acquirer to provide information, should not be allowed.

l The evaluation period which prevents acquisitions from moving forward should be limited to 30 working days maximum to be consistent with the duration considered sufficient for the passive market checks for management buyouts.

l The Study Group should discuss the positive elements on hostile acquisitions made by financial buyers and discuss what should be required of them post- acquisition

Joe Bauernfreund, CEO of AVI, stated:

"A fairer and more transparent system for hostile and unsolicited takeover bids in Japan will allow for a more active takeover market that should led to enhanced corporate value for shareholders."

 

"We at AVI are encouraged that the METI study group recognises the positive impact that unsolicited takeovers can have in a healthy functioning market."

 

Contact details:

Daniel Lee, Head of Japan Research

+44 20 7659 4809

daniel.lee@assetvalueinvestors.com

 

Kaz Sakai, Senior Japan Analyst

+44 20 7659 4818

kaz.sakai@assetvalueinvestors.com

 

 

 

AVI at a glance

AVI is an investment management company established in London, United Kingdom, in 1985, and AVI has invested in Japanese equities for more than 20 years. AVI manages AVI Global Trust (AUM: approximately JPY172bn (£1.1bn)), AVI Japan Opportunities Trust (AUM: approximately JPY27bn (£0.17bn)), etc., as of 31 January 2023. AGT and AJOT are public companies whose shares are listed and traded on the main market of the London Stock Exchange. The AVI-Managed Funds are characterised by the fact that they are closed-ended investment trust companies meaning that there are no restrictions constraining the length of the investment period. This means that, so long as AVI perceives an investment to be undervalued and has identified a catalyst for unlocking that value, AVI can continue to hold the investment indefinitely.

AVI has signified its commitment to the "Principles for Responsible Institutional Investors: Japan's Stewardship Code" (the "Stewardship Code") and, in accordance with its intent, engages in constructive "purposeful dialogue" (engagement) with management and board members in order to contribute to the enhancement of the corporate value and sustainable growth of the portfolio companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKCBNPBKDBNB
Date   Source Headline
3rd May 202412:59 pmRNSNet Asset Value(s)
2nd May 202412:20 pmRNSNet Asset Value(s)
1st May 20242:49 pmRNSResult of AGM
1st May 202412:52 pmRNSNet Asset Value(s)
30th Apr 202412:35 pmRNSNet Asset Value(s)
29th Apr 20241:15 pmRNSNet Asset Value(s)
26th Apr 20243:02 pmRNSNet Asset Value(s)
25th Apr 20243:34 pmRNSNet Asset Value(s)
24th Apr 202412:40 pmRNSNet Asset Value(s)
23rd Apr 202412:25 pmRNSNet Asset Value(s)
22nd Apr 20241:04 pmRNSNet Asset Value(s)
19th Apr 202412:32 pmRNSNet Asset Value(s)
18th Apr 202412:45 pmRNSNet Asset Value(s)
17th Apr 20243:05 pmRNSNet Asset Value(s)
16th Apr 202412:29 pmRNSNet Asset Value(s)
15th Apr 20241:18 pmRNSNet Asset Value(s)
12th Apr 20245:33 pmRNSQuarterly Newsletter
12th Apr 20245:03 pmRNSMonthly Update
12th Apr 202410:49 amRNSNet Asset Value(s)
11th Apr 202411:51 amRNSNet Asset Value(s)
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 202412:18 pmRNSNet Asset Value(s)
8th Apr 202412:20 pmRNSNet Asset Value(s)
5th Apr 202412:56 pmRNSNet Asset Value(s)
4th Apr 20241:01 pmRNSNet Asset Value(s)
3rd Apr 202412:54 pmRNSNet Asset Value(s)
2nd Apr 20243:28 pmRNSNet Asset Value(s)
2nd Apr 202411:03 amRNSTotal Voting Rights
28th Mar 202411:55 amRNSNet Asset Value(s)
27th Mar 20242:58 pmRNSNet Asset Value(s)
26th Mar 20243:49 pmRNSDirector/PDMR Shareholding
26th Mar 202412:56 pmRNSNet Asset Value(s)
25th Mar 20243:16 pmRNSNet Asset Value(s)
22nd Mar 202412:57 pmRNSNet Asset Value(s)
21st Mar 202411:07 amRNSNet Asset Value(s)
20th Mar 202412:13 pmRNSNet Asset Value(s)
19th Mar 20245:34 pmRNSMonthly update
19th Mar 20242:39 pmRNSNet Asset Value(s)
18th Mar 20242:23 pmRNSNet Asset Value(s)
15th Mar 20245:29 pmRNSTransaction in Own Shares
15th Mar 20241:29 pmRNSNet Asset Value(s)
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20241:49 pmRNSInvestment Manager Increases Holding
14th Mar 20241:19 pmRNSNet Asset Value(s)
14th Mar 20247:00 amRNSAnnual Financial Report
13th Mar 202412:31 pmRNSNet Asset Value(s)
12th Mar 202412:34 pmRNSNet Asset Value(s)
11th Mar 202412:52 pmRNSNet Asset Value(s)
8th Mar 202412:37 pmRNSNet Asset Value(s)
7th Mar 20241:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.